PEX5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.699400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.655600E-01
Normal-vs-Stage2
8.773200E-01
Normal-vs-Stage3
3.552000E-01
Normal-vs-Stage4
5.901600E-01
Stage1-vs-Stage2
2.162800E-01
Stage1-vs-Stage3
1.166020E-01
Stage1-vs-Stage4
2.189400E-01
Stage2-vs-Stage3
4.594400E-01
Stage2-vs-Stage4
8.524800E-01
Stage3-vs-Stage4
4.610800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.776800E-01
Normal-vs-AfricanAmerican
4.529200E-01
Normal-vs-Asian
2.894200E-01
Caucasian-vs-AfricanAmerican
1.814000E-01
Caucasian-vs-Asian
1.502770E-01
AfricanAmerican-vs-Asian
4.810800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.419000E-01
Normal-vs-Female
8.272800E-01
Male-vs-Female
3.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.938600E-01
Normal-vs-Age(41-60Yrs)
7.947400E-01
Normal-vs-Age(61-80Yrs)
8.388600E-01
Normal-vs-Age(81-100Yrs)
8.758200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.047600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.058800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.287200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.197810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.585600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.124600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.592800E-01
Normal-vs-Daily Drinker
5.034400E-01
Normal-vs-Weekly Drinker
5.776200E-01
Normal-vs-Occasional Drinker
5.199800E-01
Normal-vs-Social Drinker
7.894400E-01
Non Drinker-vs-Daily Drinker
2.616600E-01
Non Drinker-vs-Weekly Drinker
3.905600E-01
Non Drinker-vs-Occasional Drinker
4.670800E-01
Non Drinker-vs-Social Drinker
7.465400E-01
Daily Drinker-vs-Weekly Drinker
7.605200E-01
Daily Drinker-vs-Occasional Drinker
1.604030E-02
Daily Drinker-vs-Social Drinker
1.185800E-01
Weekly Drinker-vs-Occasional Drinker
4.390200E-02
Weekly Drinker-vs-Social Drinker
2.371600E-01
Occasional Drinker-vs-Social Drinker
7.776600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.752100E-02
Normal-vs-Grade 2
5.306200E-02
Normal-vs-Grade 3
1.872200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.262300E-02
Grade 1-vs-Grade 3
8.776400E-02
Grade 1-vs-Grade 4
3.752100E-02
Grade 2-vs-Grade 3
6.779800E-01
Grade 2-vs-Grade 4
5.306200E-02
Grade 3-vs-Grade 4
1.872200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.762800E-01
Normal-vs-NonDiabetic
8.894800E-01
Diabetic-vs-NonDiabetic
8.319400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.684400E-01
Normal-vs-NoPancreatitis
8.753400E-01
Pancreatitis-vs-NoPancreatitis
4.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.505200E-01
Normal-vs-N1
7.804000E-01
N0-vs-N1
1.902750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.068200E-01
Normal-vs-TP53-NonMutant
7.971400E-01
TP53-Mutant-vs-TP53-NonMutant
4.762500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
